Abstract
Osteoarthritis (OA) is a highly prevalent, disabling disease, with a commensurate tremendous individual and socioeconomic burden. This Perspectives article focuses on the burden of OA for the individual, the health-care system and society, to draw attention to the magnitude of the current problem with some reference to projected figures. We have an urgent opportunity to make fundamental changes to the way we care for individuals with OA that will have an effect upon the direct and indirect costs of this disease. By focusing on the burden of this prevalent, disabling, and costly disease, we hope to highlight the opportunity for shifts in health-care policy towards prevention and chronic-disease management.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of intra-articular injection of platelet-rich plasma on the inflammatory process and histopathological characteristics of cartilage and synovium in animals with osteoarthritis: a systematic review with meta-analysis
Advances in Rheumatology Open Access 29 March 2024
-
5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
Nature Communications Open Access 03 February 2024
-
Klf10 is involved in extracellular matrix calcification of chondrocytes alleviating chondrocyte senescence
Journal of Translational Medicine Open Access 13 January 2024
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Centers for Disease Control and Prevention (CDC). Prevalence and impact of chronic joint symptoms—seven states, 1996. MMWR Morb. Mortal. Wkly Rep. 47, 345–351 (1998).
Dunlop, D. D., Manheim, L. M., Song, J. & Chang, R. W. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum. 44, 212–221 (2001).
Hunter, D. J. Lower extremity osteoarthritis management needs a paradigm shift. Br. J. Sports Med. 45, 283–288 (2011).
Hootman, J. M. & Helmick, C. G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 54, 226–229 (2006).
Perruccio, A. V., Power, J. D. & Badley, E. M. Revisiting arthritis prevalence projections—it's more than just the aging of the population. J. Rheumatol. 33, 1856–1862 (2006).
Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb. Mortal. Wkly Rep. 50, 120–125 (2001).
Guccione, A. A. et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am. J. Pub. Health 84, 351–358 (1994).
Vos, T. et al. Years lived with disability (YLDs) for 1,160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163–2196 (2012).
Murray, C. J. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197–2223 (2013).
Hawker, G. A. et al. Understanding the pain experience in hip and knee osteoarthritis—an OARSI/OMERACT initiative. Osteoarthritis Cartilage 16, 415–422 (2008).
Dieppe, P. A. & Lohmander, L. S. Pathogenesis and management of pain in osteoarthritis. Lancet 365, 965–973 (2005).
Hunter, D. J., McDougall, J. J. & Keefe, F. J. The symptoms of osteoarthritis and the genesis of pain. Rheum. Dis. Clin. N. Am. 34, 623–643 (2008).
Wilkie, R., Peat, G., Thomas, E. & Croft, P. Factors associated with restricted mobility outside the home in community-dwelling adults ages fifty years and older with knee pain: an example of use of the International Classification of Functioning to investigate participation restriction. Arthritis Rheum. 57, 1381–1389 (2007).
Hawker, G. A. Experiencing painful osteoarthritis: what have we learned from listening? Curr. Opin. Rheumatol. 21, 507–512 (2009).
Hawker, G. A. et al. The multidimensionality of sleep quality and its relationship to fatigue in older adults with painful osteoarthritis. Osteoarthritis Cartilage 18, 1365–1371 (2010).
Centers for Disease Control and Prevention (CDC). National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions—United States, 2003. MMWR Morb. Mortal. Wkly Rep. 56, 4–7 (2007).
Nuesch, E. et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 342, d1165 (2011).
Losina, E. et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older americans. Ann. Intern. Med. 154, 217–226 (2011).
Lawrence, R. C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41, 778–799 (1998).
Zhang, Y. et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. Am. J. Epidemiol. 156, 1021–1027 (2002).
Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26–35 (2008).
March, L. M. & Bachmeier, C. J. Economics of osteoarthritis: a global perspective. Baillieres Clin. Rheum. 11, 817–834 (1997).
Gupta, S., Hawker, G. A., Laporte, A., Croxford, R. & Coyte, P. C. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford) 44, 1531–1537 (2005).
Kotlarz, H., Gunnarsson, C. L., Fang, H. & Rizzo, J. A. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 60, 3546–3553 (2009).
Wright, E. A. et al. Impact of knee osteoarthritis on health care resource utilization in a US population-based national sample. Med. Care 48, 785–791 (2010).
Hiligsmann, M. et al. Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin. Arthritis Rheum. 43, 303–313 (2013).
Matthews, G. L. & Hunter, D. J. Emerging drugs for osteoarthritis. Expert Opin. Emerg. Drugs 16, 479–491 (2011).
Losina, E. et al. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthritis Cartilage 21, 655–667 (2013).
Le, P. C., Reygrobellet, C. & Gerentes, I. Financial cost of osteoarthritis in France. The “COART” France study. Joint Bone Spine 72, 567–570 (2005).
Leardini, G. et al. Direct and indirect costs of osteoarthritis of the knee. Clin. Exp. Rheumatol. 22, 699–706 (2004).
Loza, E. et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 61, 158–165 (2009).
Mongan, J. J., Ferris, T. G. & Lee, T. H. Options for slowing the growth of health care costs. N. Engl. J. Med. 358, 1509–1514 (2008).
Lungren, M. P. et al. Physician self-referral: frequency of negative findings at MR imaging of the knee as a marker of appropriate utilization. Radiology 269, 810–815 (2013).
Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: Nationwide Inpatient Sample (NIS), 1999–2008 [online], (2012).
Kurtz, S., Ong, K., Lau, E., Mowat, F. & Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89, 780–785 (2007).
Li, X., Gignac, M. A. & Anis, A. H. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med. Care 44, 304–310 (2006).
Dunlop, D. D., Manheim, L. M., Yelin, E. H., Song, J. & Chang, R. W. The costs of arthritis. Arthritis Rheum. 49, 101–113 (2003).
Schofield, D. et al. Modelling the cost of ill health in Health&WealthMOD (Version II): lost labour force participation, income and taxation, and the impact of disease prevention. Int. J. Microsimulation 4, 32–36 (2011).
Kotlarz, H., Gunnarsson, C. L., Fang, H. & Rizzo, J. A. Osteoarthritis and absenteeism costs: evidence from US National Survey Data. J. Occup. Environ. Med. 52, 263–268 (2010).
Centers for Disease Control and Prevention Public Health Service US Department of Health and Human Services. Osteoarthritis and you: patient information from the CDC. J. Pain Palliat. Care Pharmacother. 24, 430–431 (2010).
Hubertsson, J., Petersson, I. F., Thorstensson, C. A. & Englund, M. Risk of sick leave and disability pension in working-age women and men with knee osteoarthritis. Ann. Rheum. Dis. 72, 401–405 (2013).
Zhang, W., Gignac, M. A., Beaton, D., Tang, K. & Anis, A. H. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J. Rheumatol. 37, 1805–1814 (2010).
Schofield, D. J., Shrestha, R. N., Passey, M. E., Earnest, A. & Fletcher, S. L. Chronic disease and labour force participation among older Australians. Med. J. Aust. 189, 447–450 (2008).
Schofield, D. J. et al. The personal and national costs of lost labour force participation due to arthritis: an economic study. BMC Public Health 13, 188 (2013).
Schofield, D. J. et al. Economic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending. BMC Public Health 11, 418 (2011).
Arthritis Australia. Painful realities: the economic impact of arthritis in Australia in 2007 (Access Economics, Sydney, 2007).
Felson, D. T. & Zhang, Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 41, 1343–1355 (1998).
Brand, C. et al. Improving care for people with osteoarthritis of the hip and knee: how has national policy for osteoarthritis been translated into service models in Australia? Int. J. Rheum. Dis. 14, 181–190 (2011).
Institute for Health Metrics and Evaluation (IHME). GBD 2010 change in leading causes and risks between 1990 and 2010. Seattle, WA: IHME, University of Washington, 2012 [online], (2014).
Arthritis and Osteoporosis Victoria. A problem worth solving: the rising cost of musculoskeletal conditions in Australia (Arthritis and Osteoporosis Victoria, Elsternwick, 2013).
Acknowledgements
D.J.H.'s work is funded by an Australian Research Council Future Fellowship (FT0991246). The comments and editorial expressed in this article represent those of the authors and do not reflect those of any official scientific role or institution that the authors may hold or be affiliated with.
Author information
Authors and Affiliations
Contributions
D.J.H. and E.C. researched data for the article, and D.J.H., D.S. and E.C. made substantial contributions to discussion of the content, writing, and review/editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hunter, D., Schofield, D. & Callander, E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 10, 437–441 (2014). https://doi.org/10.1038/nrrheum.2014.44
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.44
This article is cited by
-
Effects of intra-articular injection of platelet-rich plasma on the inflammatory process and histopathological characteristics of cartilage and synovium in animals with osteoarthritis: a systematic review with meta-analysis
Advances in Rheumatology (2024)
-
Klf10 is involved in extracellular matrix calcification of chondrocytes alleviating chondrocyte senescence
Journal of Translational Medicine (2024)
-
5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
Nature Communications (2024)
-
Burden evaluation and prediction of osteoarthritis and site-specific osteoarthritis coupled with attributable risk factors in China from 1990 to 2030
Clinical Rheumatology (2024)
-
Transplantation of Gelatin Microspheres Loaded with Wharton's Jelly Derived Mesenchymal Stem Cells Facilitates Cartilage Repair in Mice
Tissue Engineering and Regenerative Medicine (2024)